AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study

AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a ...
Gastroenterology Advisor

Rinvoq Receives FDA Approval for Updated IBD Indications

The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.

AbbVie's Rinvoq shows superiority over Humira in head-to-head study

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller ...

3 Top Dividend Growth Stocks to Buy Right Now

This lens points to three standouts in retail, healthcare, and consumer goods. One pairs a modest yield with rapid hikes ...
The American Journal of Managed Care

FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

Abivax: Betting Big On The Next Inflammatory Bowel Disease Blockbuster

ABIVAX Société Anonyme's Obefazimod shows robust efficacy and differentiation in early Phase 3 trials. Click here to read why ...